BR9611047A - Processo de deteção de ciclo oxigenase-2 - Google Patents
Processo de deteção de ciclo oxigenase-2Info
- Publication number
- BR9611047A BR9611047A BR9611047-3A BR9611047A BR9611047A BR 9611047 A BR9611047 A BR 9611047A BR 9611047 A BR9611047 A BR 9611047A BR 9611047 A BR9611047 A BR 9611047A
- Authority
- BR
- Brazil
- Prior art keywords
- oxygenase
- cycle
- detection process
- mammal
- detected
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Compounds Of Unknown Constitution (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Patente de Invenção:<B>"PROCESSO DE DETEçãO DE CICLO OXIGENASE-2"<D>. A invenção refere-se a um processo de deteção de concentrações de ciclo oxigenase-2 em um mamífero, o processo compreendendo: administração ao mamífero de uma quantidade diagnosticamente efetiva de um agente seletivo de ciclo oxigenase-2, que seja capaz de ser detectado in vivo; e b) deteção do agente e assim a concentração de ciclo oxigenase-2 é detectada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US568695P | 1995-10-17 | 1995-10-17 | |
PCT/US1996/016440 WO1997014679A2 (en) | 1995-10-17 | 1996-10-16 | Method of detecting cyclooxygenase-2 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9611047A true BR9611047A (pt) | 2000-03-08 |
Family
ID=21717184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9611047-3A BR9611047A (pt) | 1995-10-17 | 1996-10-16 | Processo de deteção de ciclo oxigenase-2 |
Country Status (10)
Country | Link |
---|---|
US (2) | US6045773A (pt) |
EP (1) | EP0859642A2 (pt) |
JP (1) | JP2000510816A (pt) |
KR (1) | KR19990064310A (pt) |
AU (1) | AU716582B2 (pt) |
BR (1) | BR9611047A (pt) |
CA (1) | CA2234633A1 (pt) |
NO (1) | NO981708L (pt) |
NZ (1) | NZ322674A (pt) |
WO (1) | WO1997014679A2 (pt) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
US5908858A (en) | 1996-04-05 | 1999-06-01 | Sankyo Company, Limited | 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
USRE39708E1 (en) | 1998-08-07 | 2007-06-26 | Chiron Corporation | Estrogen receptor modulators |
WO2002012445A1 (en) | 2000-08-07 | 2002-02-14 | Vanderbilt University | Detection of cox-2 activity and anandamide metabolites |
ES2441874T3 (es) * | 2001-06-12 | 2014-02-06 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos |
WO2003031419A1 (en) | 2001-10-09 | 2003-04-17 | 3-Dimensional Pharmaceuticals, Inc. | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes |
US7154007B2 (en) | 2001-10-10 | 2006-12-26 | Hitachi High-Technologies Corporation | Luminous compounds and labeling reagents using the same |
US7329401B2 (en) * | 2002-04-15 | 2008-02-12 | The Regents Of The University Of California | Cyclooxygenase-2 selective agents useful as imaging probes and related methods |
US7314709B2 (en) * | 2002-08-06 | 2008-01-01 | Vanderbilt University | Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism |
AU2003270752A1 (en) * | 2002-09-27 | 2004-04-19 | King Pharmaceuticals Research And Development, Inc. | A method to demonstrate the efficacy of pharmacological stress agent |
TW200505446A (en) * | 2003-01-17 | 2005-02-16 | Fuj Isawa Pharmaceutical Co Ltd | Inhibitor of cox |
JP2007524630A (ja) * | 2003-06-25 | 2007-08-30 | バンダービルト・ユニバーシティ | Cox−2標的造影剤 |
US7112601B2 (en) * | 2003-09-11 | 2006-09-26 | Bristol-Myers Squibb Company | Cycloalkyl heterocycles for treating hepatitis C virus |
KR100820511B1 (ko) * | 2004-04-01 | 2008-04-11 | 파마시아 앤드 업존 캄파니 엘엘씨 | 결정성 피라졸 유도체 |
TW200603792A (en) * | 2004-04-23 | 2006-02-01 | Pharmacia & Upjohn Co Llc | Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors |
CN101031289A (zh) * | 2004-04-26 | 2007-09-05 | 范德比尔特大学 | 作为具有降低胃肠毒性的治疗剂的吲哚乙酸和茚乙酸衍生物 |
WO2005120584A2 (en) * | 2004-06-03 | 2005-12-22 | The Trustees Of Columbia University In The City Of New York | Radiolabeled arylsulfonyl compounds and uses thereof |
CA2593713A1 (en) * | 2005-01-04 | 2006-07-13 | Novartis Ag | X-ray structure of human fpps and use for selecting fpps binding compounds |
BRPI0607688A2 (pt) | 2005-02-17 | 2009-09-22 | Synta Pharmaceuticals Corp | método para inibir a polimerização de tubulina em uma célula; método para tratar ou prevenir um distúrbio proliferativo em um indivìduo; método para bloquear, ocluir ou de outro modo romper o fluxo sangüìneo na neovasculatura; composto; composição farmacêutica e uso do referido método e composto |
NL2000351C2 (nl) | 2005-12-22 | 2007-09-11 | Pfizer Prod Inc | Estrogeen-modulatoren. |
TW200803903A (en) * | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
NZ573363A (en) * | 2006-05-19 | 2012-01-12 | Nihon Mediphysics Co Ltd | Compound having affinity for amyloid based on an imidazopyridine-phenyl skeleton |
CN101528222A (zh) | 2006-06-19 | 2009-09-09 | 范德比尔特大学 | 用于诊断性和治疗性靶向cox-2的方法和组合物 |
EP2042501B1 (en) * | 2006-06-21 | 2017-04-12 | Nihon Medi-Physics Co., Ltd. | Compound having affinity for amyloid |
WO2008056481A1 (fr) * | 2006-11-09 | 2008-05-15 | Nihon Medi-Physics Co., Ltd. | Agent d'imagerie de diagnostic radioactif |
CN101535309A (zh) * | 2006-11-17 | 2009-09-16 | 日本医事物理股份有限公司 | 对淀粉状蛋白具有亲和性的新化合物 |
US8207189B2 (en) * | 2006-11-30 | 2012-06-26 | Nihon Medi-Physics Co., Ltd. | Compound having affinity for amyloid |
PL2106808T3 (pl) * | 2006-12-21 | 2018-07-31 | Nihon Medi-Physics Co., Ltd. | Promieniotwórczy znacznik do obrazowania diagnostycznego zawierający kwas 1-amino-3-[18F]fluorocyklobutanokarboksylowy |
CN101626787A (zh) * | 2007-01-19 | 2010-01-13 | 马林克罗特公司 | 诊断的和治疗的环氧合酶-2结合配体 |
CN101636183B (zh) | 2007-02-13 | 2014-03-19 | 日本医事物理股份有限公司 | 放射性诊断显像剂的制备方法 |
AU2008274941A1 (en) | 2007-07-12 | 2009-01-15 | Tragara Pharmaceuticals, Inc. | Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
AU2008314870A1 (en) * | 2007-10-24 | 2009-04-30 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
WO2009057576A1 (ja) * | 2007-10-30 | 2009-05-07 | Nihon Medi-Physics Co., Ltd. | 新規アミロイド親和性化合物の使用及び製造方法 |
EP2216052A4 (en) * | 2007-10-30 | 2012-11-21 | Nihon Mediphysics Co Ltd | USE OF A NEW COMPOUND WITH AFFINITY FOR AMYLOID AND METHOD FOR THE PRODUCTION THEREOF |
FR2926079B1 (fr) | 2008-01-03 | 2012-12-28 | Commissariat Energie Atomique | Procede de preparation d'un derive de purine marque, ledit derive et ses utilisations |
EP2247558B2 (en) * | 2008-02-14 | 2024-07-03 | Eli Lilly and Company | Novel imaging agents for detecting neurological dysfunction |
US8932557B2 (en) | 2008-02-14 | 2015-01-13 | Eli Lilly And Company | Imaging agents for detecting neurological dysfunction |
CA2731738A1 (en) | 2008-07-24 | 2010-01-28 | Siemens Medical Solutions Usa, Inc. | Imaging agents useful for identifying ad pathology |
US8691187B2 (en) | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
WO2010111303A2 (en) | 2009-03-23 | 2010-09-30 | Siemens Medical Solutions Usa, Inc. | Imaging agents for detecting neurological disorders |
WO2013059245A1 (en) | 2011-10-17 | 2013-04-25 | Vanderbilt University | Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
WO2015200187A1 (en) | 2014-06-27 | 2015-12-30 | Reiley Pharmaceuticals, Inc. | Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging |
EP3242688B1 (en) | 2015-01-09 | 2020-01-29 | Reiley Pharmaceuticals, Inc. | Cox-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers |
US20210270834A1 (en) * | 2018-06-08 | 2021-09-02 | Kyungpook National University Industry-Academic Cooperation Foundation | Composition for diagnosing diseases associated with cox2 overexpression and screening method therefor |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5045303A (en) * | 1985-05-17 | 1991-09-03 | Neorx Corporation | Radiohalogenated small molecules for protein labeling |
IL84944A (en) * | 1987-01-19 | 1992-02-16 | Ici Plc | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation |
US5604260A (en) * | 1992-12-11 | 1997-02-18 | Merck Frosst Canada Inc. | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
DE69406903T2 (de) * | 1993-01-15 | 1998-04-09 | Searle & Co | 3,4-diarylthiophene und analoga davon, sowie deren verwendung als entzündungshemmende mittel |
US5409944A (en) * | 1993-03-12 | 1995-04-25 | Merck Frosst Canada, Inc. | Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase |
AU6718494A (en) * | 1993-05-13 | 1994-12-12 | Merck Frosst Canada Inc. | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase |
US5380738A (en) * | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
WO1995005395A1 (fr) * | 1993-08-17 | 1995-02-23 | Fujisawa Pharmaceutical Co., Ltd. | Procede de diagnostic de la maladie d'alzheimer |
US5344991A (en) * | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
ATE212985T1 (de) * | 1993-11-30 | 2002-02-15 | Searle & Co | Tricyclische,substituierte pyrazolyl- benzolsulfonamide und ihre verwendung als cyclooxygenase ii inhibitoren |
US5459239A (en) * | 1994-01-24 | 1995-10-17 | Merck Frosst Canada Inc. | Peptide sequences and antipeptide antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 proteins |
US5393790A (en) * | 1994-02-10 | 1995-02-28 | G.D. Searle & Co. | Substituted spiro compounds for the treatment of inflammation |
US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
US5620999A (en) * | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
-
1996
- 1996-10-16 BR BR9611047-3A patent/BR9611047A/pt not_active Application Discontinuation
- 1996-10-16 JP JP09515911A patent/JP2000510816A/ja not_active Ceased
- 1996-10-16 WO PCT/US1996/016440 patent/WO1997014679A2/en not_active Application Discontinuation
- 1996-10-16 AU AU76629/96A patent/AU716582B2/en not_active Ceased
- 1996-10-16 EP EP96939457A patent/EP0859642A2/en not_active Withdrawn
- 1996-10-16 CA CA002234633A patent/CA2234633A1/en not_active Abandoned
- 1996-10-16 NZ NZ322674A patent/NZ322674A/xx unknown
- 1996-10-16 KR KR1019980702806A patent/KR19990064310A/ko not_active Application Discontinuation
-
1998
- 1998-04-16 NO NO981708A patent/NO981708L/no not_active Application Discontinuation
-
1999
- 1999-02-24 US US09/256,739 patent/US6045773A/en not_active Expired - Fee Related
-
2001
- 2001-01-09 US US09/756,893 patent/US20010055565A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU7662996A (en) | 1997-05-07 |
US20010055565A1 (en) | 2001-12-27 |
WO1997014679A2 (en) | 1997-04-24 |
CA2234633A1 (en) | 1997-04-24 |
NO981708L (no) | 1998-06-10 |
AU716582B2 (en) | 2000-03-02 |
NO981708D0 (no) | 1998-04-16 |
NZ322674A (en) | 1999-08-30 |
WO1997014679A3 (en) | 1997-08-14 |
EP0859642A2 (en) | 1998-08-26 |
US6045773A (en) | 2000-04-04 |
JP2000510816A (ja) | 2000-08-22 |
KR19990064310A (ko) | 1999-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9611047A (pt) | Processo de deteção de ciclo oxigenase-2 | |
Prescott et al. | The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage | |
BR0210579A (pt) | Anticorpos, cadeias pesadas e leves, composição farmacêutica e métodos de detecção do nìvel de opgl em amostra biológia e de tratamento | |
DE69605184D1 (de) | Verabreichung einer substanz in den mund | |
BR0115653A (pt) | Composição pronta para o uso para a descoloração ou a deformação para fibras queratìnicas, composição anidra para a descoloração ou a deformação das fibras queratìnicas, composição para a deformação permanente, processo de descoloração ou de deformação permanente das fibras queratìnicas e dispositivo com dois compartimentos ou 'kit' para a descoloração ou a deformação permanente das fibras queratìnicas humanas | |
BR9906287A (pt) | Bactéria pertencente ao gênero escherichia e que tem uma capacidade para produzir um l-aminoácido, e, processo para produzir um l-aminoácido | |
ES2155513T3 (es) | Ensayo de escrutinio para la deteccion precoz de neoplasia colorrectal. | |
BR9914873A (pt) | Sensor capaz de detectar seletivamente apresença de material fecal e artigo higiênico | |
BR9911884A (pt) | Preparação farmacêutica | |
BR9811319A (pt) | Método para proteger um animal contra umadoença crÈnica | |
ATE7107T1 (de) | Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln. | |
BR9609677A (pt) | Analisadores de função pulmonar pessoal. | |
FR2627084B1 (fr) | Formes galeniques solides contenant une ou plusieurs substances peroxydiques liberant de l'oxygene actif et utilisees en hygiene bucco-dentaire ou comme decontaminants de lentilles ophtalmiques | |
BR9400807A (pt) | Método para medir diretamente a concentração de um ou mais componentes de composições de tratamento de água, métodos para determinar os ciclos de concentração, os requisitos de dosagem de polímero e a perda de polímero em um sistema gerador de vapor d'agua | |
CY1107921T1 (el) | Μεθοδος για την προγνωση της αθροιστικης επιβιωσης ασθενων | |
BRPI0408507A (pt) | sistema de oxidação contendo um complexo de metal macrocìclico, sua preparação e aplicação | |
ES2061007T3 (es) | Preparacion farmaceutica que contiene proteina-s. | |
RU94020406A (ru) | Способ выявления поражений эпителия желудка и применение дисахаридов для этой цели | |
KR920014474A (ko) | 담석 붕괴용 제제 | |
Spears et al. | Influence of clozapine on water dysregulation. | |
Ghael et al. | The nitric oxide donor S‐nitroso‐N‐acetyl‐D, L‐penicillamine degrades heparan sulfate and heparin | |
BR9507228A (pt) | Processo para detectar a presença de um analito em uma amostra de um fluido corpóreo soluçao tampao para o tratamento de uma amostra de fluido corpóreo a ser ensaiada e kit | |
Vorum et al. | Valproate competes with palmitate for binding to serum albumin | |
EA200700968A1 (ru) | Фармацевтическая композиция для лечения сахарного диабета 2 типа | |
佐々木優 | Histomorphometric Analysis of Age-Related Changes in Epithelial Thickness and Langerhans Cell Density of the Human Tongue. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.PORTANTO, INDEFIRO O PRESENTE PEDIDO. |